About Us

We are creating an exciting and dynamic team to deliver our technology platform of Tissue Preservation to physicians for their patients. Our effort is the culmination of the combined vision and work of patients, physicians, scientists, and medical device executives. All of us understand the great importance that Tissue Preservation will serve in modern healthcare.

Jeffrey W. Morrill
President and Chief Executive Officer

Prior to joining NuOrtho Surgical, Inc., Mr. Morrill was Chief Marketing Officer for Vetrix, an internationally funded start-up company. Previously, he served as Director of Marketing at Johnson & Johnson's DePuy Mitek leading the entry into the $2B Capital Equipment category with differentiated brands. He has also served in various senior Marketing and Sales roles at Johnson & Johson's McNeil, the Borden Food Company, and Nestle. He has broad experience in creating new products, gaining FDA approval, and commercializing products worldwide. Educated at DePaul University receiving his MBA and at Lafayette College receiving his Bachelor of Arts.

Roy E. Morgan, PE, PMP
Chief Development Officer

Mr. Morgan has 18 years experience as a Project Engineer. Prior to joining NuOrtho Surgical, Inc., Mr. Morgan served as Director of Research and Development at Nipro; Research and Development Engineer Manager at Abbott Labs; Director of Research and Development at Artemis Medical; and Research and Development Engineering Manager Stryker Endoscopy. He has successfully developed multiple products and achieved FDA approval in both a start up and corporate environment. He received his BSc from Brown University and received his Registered Professional Engineer and certificate in Project Managementmark at University of Califonia at Berkley.

Wayne K. Auge II, MD
Chief Clinical Officer

Dr. Auge is a Board Certified Orthopedic Surgeon and Fellow of the American Academy of Orthopedic Surgeons specializing in the care of the knee and shoulder. He received his Doctorate of Medicine from Northwestern University of Chicago and completed his Fellowship at the Southern California Center for Sports Medicine. www.augeMD.com

Brant A. Bair, MD
Chairman, Advisory Panel

Dr. Bair is a Board Certified member of the American Academy of Orthopaedic Surgeons. He is currently Chief of Staff at Physicians Medical Center in Santa Fe, New Mexico and is also on staff as Assistant Clinical Professor at the University of New Mexico. He obtained his Doctorate of Medicine from Indiana University Medical School and completed the Sports Medicine Fellowship at The Orthopaedic Specialty Hospital in Salt Lake City, Utah. While in Salt Lake he participated as a traveling physician with the U.S. Ski Team. Dr. Bair has published on knee procedures and has been a speaker at industry meetings.

Steven D. Jones, DO
Member, Advisory Panel

Dr. Jones received a Bachelors degree in mechanical engineering and Doctorate of Osteopathic Medicine from Oklahoma State University. He completed a Fellowship at the University of Arkansas for Medical Sciences in Adult Reconstruction and is currently practicing at the Northern New Mexico Orthopaedic Center.

Jeremy B. Stern, MD
Member, Advisory Panel

Dr. Stern is a Board Certified member of the American Academy of Orthopaedic Surgeons. He currently serves as Chief of Orthopaedics at St. Lukes Hospital, as the Surgical Director of the Southcoast Surgical Center, and the Director of Sports Medicine and Rehabillitation for Southcoast Hospitals at Mashpee. He received his Doctorate of Medicine from Albert Einstein College of Medicine and completed a Sports Medicine and Arthroscopy Fellowship at The Orthopaedic Specialty Hospital in Salt Lake City, Utah.

Karin Gregory, Esq.
Member, Advisory Panel

Ms. Gregory's career spans over 25 years in the healthcare field, as a basic scientist, healthcare administrator, lawyer, and venture capitalist. She is currently at Furman Gregory, LLC where she represents early stage healthcare and technology companies. She serves as an investment professional at the Massachusetts Technology Development Corporation (MTDC), an early stage Boston state-sponsored venture capital firm. She co-founded Dover Medical Ventures, LP, an early stage medical device venture capital fund; and, eMedicus, Inc., a commercial IRB for the review and monitoring of clinical research studies being conducted by pharmaceutical and device companies in the field of oncology

Patrick Janin
Member, Advisory Panel

Mr. Janin is a seasoned executive with a track record of building new innovative products and companies. His most recent role was as President of Future Medical Systems with an innovative arthroscopic fluid management system. He built the system and team which led to leading market shares in both the US and EU with total revenues of $50 million. He led the sale of the company and the successful integration of the business into Johnson & Johnson DePuy Mitek.

Chris Heye
Member, Advisory Panel

Mr. Heye is a seasoned executive with over 20 years of experience in marketing leadership roles in private and public firms. He is currently Chief Marketing Officer for all business units of Welch's. He has successfully grown existing brands and introduced new products founded on innovative ideas. He has held various sales and marketing roles at BP/Castrol, Johnson & Johnson, and Nestle. While Vice President of Marketing at BP/Castrol, he led marketing for 40 countries managing a total of $1.6 billiion in revenue.




Heber E. Saravia
Design Development

Mr.Saravia has sixteen years of experience in the medical device industry. He has produced mechanical designs and analyses for more than 35 projects that include catheters, guide-wires, stent-delivery devices, drug delivery pumps, surgical pumps, hand-operated surgical tools, arthroscopic and laparoscopic instruments, electronic enclosures, hand-held electronic instruments, RF instruments, suture devices, implants, and others. He was recently named to the MD&DI’s top-100 most influential people in the medical device industry for 2008. He is also named inventor in 12 granted patents and 12 patents pending. He has a B.S. degree in Aeronautical Engineering from California Polytechnic State University, SLO and M.S. degree in Mechanical Engineering from San José State University.

Nelson O. Lam
Quality Assurance and Regulatory Affairs

Nelson Lam, principal consultant at Nelson Lam & Associates, began his practice in 2005 principally focused on serving early-stage medical device companies transitioning from research & development to commercialization. He brings with him over 17 years of industry experience in Quality Assurance and Regulatory Affairs working with Class I, II and II devices. In his last professional position, Nelson served as the VP of Quality, Regulatory and Clinical Affairs at Abbott Diabetes Care/TheraSense. There, from ground- up, he established a quality management system and QA/RA organization to support worldwide product approval and commercialization. Prior to Abbott, Nelson held various senior positions in Quality and Regulatory in a mix of public and private, mature and start- up medical device companies. In his current practice, Nelson and his team of seasoned professionals provide services in the areas of quality management system development, FDA 510k and PMA submissions, regulatory and clinical strategic planning, compliance auditing, facilitation of regulatory inspections, project management and certification to CE Mark & ISO 13485.

Janeen Viven-Doggett, PhD, Esq
Intellectual Property Counsel

Janeen Vilven-Doggett is a registered patent attorney practicing in the fields of medical device, biotechnology, nanotechnology, and optics. She also handles trademark, intellectual property litigation and licensing matters. Dr. Vilven-Doggett received her B.A. in Biology from Baylor University in 1986 and her Ph.D. in Biomedical Sciences from the University of New Mexico in 1997. She received her J.D. (cum laude) from the University of New Mexico School of Law in 2001. Upon graduation from law school in 2001, Dr. Vilven-Doggett joined the firm of Roberts Abokhair & Mardula in Restin, Virginia and Corrales, New Mexico as an associate attorney working in patent, trademark, and copyright prosecution and litigation. She is currently a Patent Attorney with Peacock Myers, P.C. in Albuquerque, New Mexico. Dr. Vilven- Doggett is a member of the Board of NMBIO and a member of the IP Counsel Committee of BIO.

Christine E. Cahill
Senior Vice President, Boston Private Bank & Trust Company

Boston Private Bank & Trust Company is a full service commercial bank that provides financial planning, private banking and investment management strategies for corporate, philanthropic and individual clients. The bank provides basic banking services for the true start-up company, services tailored to private equity firms, and a full complement of banking products and commercial credit facilities for privately held businesses.

Christine Cahill is a seasoned banker with 20 years of banking experience specializing in business development and client relationship management. She holds a Masters Degree from Boston University and a Bachelor’s Degree from Boston College and in 2008 she was named one of the Top Ten Boston Bankers by Women’s Business Journal.

Scott Kapowitch
CPA

The firm was founded in 1968 by Alan M. Edelstein, a well known and respected CPA in Massachusetts. Two of our current partners joined the firm directly out of college. Many of our staff have also been with us since college. We take great pride in the years of dedicated service our partners and staff have provided to our clients. We foster an atmosphere that encourages individual and professional growth, which ultimately translates to outstanding and consistent client service.

The firm has grown steadily as a result of our clients' internal growth, and through referrals from existing clients and business associates. Today we have grown to a firm with 9 partners and over 45 other professionals serving hundreds of clients. Our growth over the past few years has been exciting but we have purposely managed our growth to ensure that the same level of client service is given now as was provided when Alan Edelstein was a sole practitioner over forty years ago.

The firm is affiliated with Edelstein Wealth Management, LLC, a separate entity that provides personal financial planning services.

Leslie Jorgensen

Supporting Strategies provides outsourced accounting services and operational support for emerging and small businesses. Founded in 2004, the company has quickly become a go-to service provider for high-tech and biotechnology start-ups, professional service firms, and other entrepreneurial businesses. Supporting Strategies provides a full range of services including bookkeeping, accounts payable, accounts receivable, budgeting, forecasting, financial reporting, human resources support, among others. With more than 50 years collective experience, the Supporting Strategies team provides every client with a unique set of services tailored to support its strategic business objectives and budget.

Darik Volpa
Founder and CEO, Understand.com

Mr. Volpa is the Founder and CEO of Understand.com, a global provider of health care content that helps surgeons better communicate with patients using 3D animation.

Mr. Volpa gained much of his experience at Stryker Corporation, a $5 billion medical device company where he managed more than $50 million in products and was responsible for the development and launch of over 50 medical devices. He earned numerous awards at Stryker including Marketing Professional of the Year and the Rolex Award for Sales Performance.

In 2006, Mr. Volpa was awarded "Best of Show" at the Silver & Gold Venture Capital Conference representing Understand.com. Mr. Volpa was named the 2007 Innovator of the Year by The Business Report of Northern Nevada and received Senatorial recognition from Nevada Senator John Ensign.

Mr. Volpa resides in Reno, Nevada with his wife Tiffany and daughters Morgan and Tatum.

Karin Gregory, Esq.

Ms. Gregory's career spans over 25 years in the healthcare field, as a basic scientist, healthcare administrator, lawyer, and venture capitalist. She is currently at Furman Gregory, LLC where she represents early stage healthcare and technology companies. She serves as an investment professional at the Massachusetts Technology Development Corporation (MTDC), an early stage Boston state-sponsored venture capital firm. She co-founded Dover Medical Ventures, LP, an early stage medical device venture capital fund; and, eMedicus, Inc., a commercial IRB for the review and monitoring of clinical research studies being conducted by pharmaceutical and device companies in the field of oncology.

Stephen McCarthy, PhD

Professor McCarthy joined the faculty of the Plastics Engineering Department at the University of Massachusetts Lowell in 1984 and is currently a tenured Full Professor. He is currently the Co-Director of the Massachusetts Medical Device Development Center at U. Mass. Lowell and U. Mass. Worcester. He is currently the the Editor for the Journal of Polymer and the Environment. He received his B.S. from Southeastern Massachusetts University, a Masters in Chemical Engineering from Princeton University, and a Ph.D. in Macromolecular Science from Case Western University in Cleveland, Ohio. He worked as an Advanced Engineer in R&D for Owens Corning Fiberglas in Granville, Ohio.

The University of Massachusetts Lowell – in partnership with the University of Massachusetts Worcester and MassMEDIC, the Massachusetts medical device industry trade association, and with the support of medical device companies and investors such as Anika Therapeutics Inc., Baril Die Company, Brook Venture Partners, Prism Venture Partners and Zoll Medical Corporation – proposes creating a Massachusetts Medical Device Development Center (M2D2) with the support of the Massachusetts Technology Collaborative. Its aim is to address the needs of emerging medical device companies in growing this critical Life Sciences industry in Massachusetts. Over five years, M2D2 could increase the number of product and company launches by 10-15% over current rates.